Stock Track | LeMaitre Vascular Soars 6.15% on Strong Q4 Results, Dividend Hike and $100M Buyback

Stock Track

Feb 26

LeMaitre Vascular's stock surged 6.15% during intraday trading on Wednesday, following the company's release of better-than-expected fourth-quarter financial results and several shareholder-friendly announcements.

The vascular device provider reported Q4 2025 earnings of $0.68 per share, beating analyst consensus estimates of $0.66, while revenue of $64.453 million exceeded expectations of $62.823 million. The company demonstrated strong growth with sales increasing 16% year-over-year and operating income jumping 47%.

Investors responded positively to the company's announcement of a 25% increase in its quarterly dividend to $0.25 per share and authorization of a $100 million share repurchase program. Additionally, LeMaitre Vascular provided optimistic guidance for 2026, forecasting continued sales and profit growth, further boosting market confidence in the company's prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1195385858"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195385858\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195385858?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 09:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195385858","market":"us","top_or_hot":-1,"title":"Stock Track | LeMaitre Vascular Soars 6.15% on Strong Q4 Results, Dividend Hike and $100M Buyback","media":"Stock Track","content":"<p>LeMaitre Vascular's stock surged 6.15% during intraday trading on Wednesday, following the company's release of better-than-expected fourth-quarter financial results and several shareholder-friendly announcements.</p><p>The vascular device provider reported Q4 2025 earnings of $0.68 per share, beating analyst consensus estimates of $0.66, while revenue of $64.453 million exceeded expectations of $62.823 million. The company demonstrated strong growth with sales increasing 16% year-over-year and operating income jumping 47%.</p><p>Investors responded positively to the company's announcement of a 25% increase in its quarterly dividend to $0.25 per share and authorization of a $100 million share repurchase program. Additionally, LeMaitre Vascular provided optimistic guidance for 2026, forecasting continued sales and profit growth, further boosting market confidence in the company's prospects.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | LeMaitre Vascular Soars 6.15% on Strong Q4 Results, Dividend Hike and $100M Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | LeMaitre Vascular Soars 6.15% on Strong Q4 Results, Dividend Hike and $100M Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-26 09:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LeMaitre Vascular's stock surged 6.15% during intraday trading on Wednesday, following the company's release of better-than-expected fourth-quarter financial results and several shareholder-friendly announcements.</p><p>The vascular device provider reported Q4 2025 earnings of $0.68 per share, beating analyst consensus estimates of $0.66, while revenue of $64.453 million exceeded expectations of $62.823 million. The company demonstrated strong growth with sales increasing 16% year-over-year and operating income jumping 47%.</p><p>Investors responded positively to the company's announcement of a 25% increase in its quarterly dividend to $0.25 per share and authorization of a $100 million share repurchase program. Additionally, LeMaitre Vascular provided optimistic guidance for 2026, forecasting continued sales and profit growth, further boosting market confidence in the company's prospects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LMAT","symbol_name":"勒梅特微管医疗","start_time":0,"source_url":"","article_id":"1195385858","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195385858","pubTimestamp":1772068480,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"LeMaitre Vascular's stock surged 6.15% during intraday trading on Wednesday, following the company's release of better-than-expected fourth-quarter financial results and several shareholder-friendly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LMAT":"勒梅特微管医疗"},"translate_title":"股票追踪|LeMaitre Vascular因强劲的第四季度业绩、股息上调和1亿美元回购而飙升6.15%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LMAT":1},"content_text":"LeMaitre Vascular's stock surged 6.15% during intraday trading on Wednesday, following the company's release of better-than-expected fourth-quarter financial results and several shareholder-friendly announcements.The vascular device provider reported Q4 2025 earnings of $0.68 per share, beating analyst consensus estimates of $0.66, while revenue of $64.453 million exceeded expectations of $62.823 million. The company demonstrated strong growth with sales increasing 16% year-over-year and operating income jumping 47%.Investors responded positively to the company's announcement of a 25% increase in its quarterly dividend to $0.25 per share and authorization of a $100 million share repurchase program. Additionally, LeMaitre Vascular provided optimistic guidance for 2026, forecasting continued sales and profit growth, further boosting market confidence in the company's prospects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}